Literature DB >> 17454452

Reactivation phenotype in rabbits of a herpes simplex virus type 1 mutant containing an unrelated antiapoptosis gene in place of latency-associated transcript.

Ling Jin1, Guey-Chuen Perng, Dale Carpenter, Kevin R Mott, Nelson Osorio, Julia Naito, David J Brick, Clinton Jones, Steven L Wechsler.   

Abstract

Latency-associated transcript (LAT) significantly enhances the spontaneous reactivation phenotype of herpes simplex virus type 1 (HSV-1). The mechanism by which LAT accomplishes this has been elusive. To determine if LAT's antiapoptosis activity is involved, the authors used a rabbit eye model to analyze the spontaneous reactivation phenotype of an HSV-1 mutant in which LAT was replaced by an unrelated antiapoptosis gene. This virus, dLAT-cpIAP, contains the open reading frame of the baculovirus inhibitor of apoptosis protein gene (cpIAP) in place of LAT, under control of the LAT promoter. The authors report here that in a rabbit ocular model of infection, dLAT-cpIAP had a spontaneous reactivation phenotype similar to wild-type virus and significantly higher than LAT(-) viruses. This was consistent with their previous findings using the mouse trigeminal ganglia explant-induced reactivation model. Whether LAT (and in the case of dLAT-cpIAP, cpIAP) enhances the spontaneous reactivation phenotype by functioning during establishment of latency, maintenance of latency, or reactivation from latency, or during two or more of these periods, remains to be determined. Regardless, the results presented in this study strongly support the hypothesis that LAT's antiapoptosis activity is the dominant function that enhances HSV-1's spontaneous reactivation phenotype.

Entities:  

Mesh:

Year:  2007        PMID: 17454452     DOI: 10.1080/13550280601164333

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  46 in total

1.  Identical 371-base-pair deletion mutations in the LAT genes of herpes simplex virus type 1 McKrae and 17syn+ result in different in vivo reactivation phenotypes.

Authors:  J M Loutsch; G C Perng; J M Hill; X Zheng; M E Marquart; T M Block; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 2.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

3.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

4.  Herpes simplex virus latent phase transcription facilitates in vivo reactivation.

Authors:  J M Hill; F Sedarati; R T Javier; E K Wagner; J G Stevens
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

5.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

6.  A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics.

Authors:  J Maggioncalda; A Mehta; O Bagasra; N W Fraser; T M Block
Journal:  J Neurovirol       Date:  1996-08       Impact factor: 2.643

7.  Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs.

Authors:  M J Birnbaum; R J Clem; L K Miller
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

9.  A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.

Authors:  W F Goins; L R Sternberg; K D Croen; P R Krause; R L Hendricks; D J Fink; S E Straus; M Levine; J C Glorioso
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Evidence that spontaneous reactivation of herpes virus does not occur in mice.

Authors:  Bryan M Gebhardt; William P Halford
Journal:  Virol J       Date:  2005-08-18       Impact factor: 4.099

View more
  17 in total

1.  Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity.

Authors:  Dale Carpenter; Gail Henderson; Chinhui Hsiang; Nelson Osorio; Lbachir BenMohamed; Clinton Jones; Steven L Wechsler
Journal:  Microb Pathog       Date:  2007-08-12       Impact factor: 3.738

2.  A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.

Authors:  Xianzhi Jiang; Don Brown; Nelson Osorio; Chinhui Hsiang; Lily Li; Lucas Chan; Lbachir BenMohamed; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-02-03       Impact factor: 2.643

3.  Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.

Authors:  Lbachir BenMohamed; Nelson Osorio; Ruchi Srivastava; Arif A Khan; Jennifer L Simpson; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-05-22       Impact factor: 2.643

4.  Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.

Authors:  Xianzhi Jiang; Don Brown; Nelson Osorio; Chinhui Hsiang; Lbachir BenMohamed; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-06-12       Impact factor: 2.643

5.  The herpes simplex virus type 1 latency-associated transcript can protect neuron-derived C1300 and Neuro2A cells from granzyme B-induced apoptosis and CD8 T-cell killing.

Authors:  Xianzhi Jiang; Aziz Alami Chentoufi; Chinhui Hsiang; Dale Carpenter; Nelson Osorio; Lbachir BenMohamed; Nigel W Fraser; Clinton Jones; Steven L Wechsler
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) protects cells against cold-shock-induced apoptosis by maintaining phosphorylation of protein kinase B (AKT).

Authors:  Dale Carpenter; Chinhui Hsiang; Xianzhi Jiang; Nelson Osorio; Lbachir BenMohamed; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-06-13       Impact factor: 2.643

7.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

8.  Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.

Authors:  Shaohui Wang; Alexander V Ljubimov; Ling Jin; Klaus Pfeffer; Mitchell Kronenberg; Homayon Ghiasi
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

9.  Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice.

Authors:  Ling Jin; Dale Carpenter; Megan Moerdyk-Schauwecker; Adam L Vanarsdall; Nelson Osorio; Chinhui Hsiang; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

10.  A speculated ribozyme site in the herpes simplex virus type 1 latency-associated transcript gene is not essential for a wild-type reactivation phenotype.

Authors:  Dale Carpenter; Sukhpreet Singh; Nelson Osorio; Chinhui Hsiang; Xianzhi Jiang; Ling Jin; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.